NBE-002 in Patients With Advanced Solid Tumors

Clinical trial NCT04441099 · TERMINATED

Trial details

NCT number: NCT04441099
Sponsor: NBE-Therapeutics AG
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Advanced Cancer Triple Negative Breast Cancer

Start date: 2020-06-19
Primary completion: 2023-08-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.